U.S. Markets close in 7 mins

Top Ranked Value Stocks to Buy for May 8th

Zacks Equity Research

Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 8th:

Health Insurance Innovations, Inc. (HIIQ): This cloud-based technology platform and distributor of health insurance plans has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 6.1% over the last 60 days.

Health Insurance Innovations, Inc. Price and Consensus

Health Insurance Innovations, Inc. Price and Consensus

Health Insurance Innovations, Inc. price-consensus-chart | Health Insurance Innovations, Inc. Quote

Health Insurance has a price-to-earnings ratio (P/E) of 6.67, compared with 7.70 for the industry. The company possesses a Value Score of A.

Health Insurance Innovations, Inc. PE Ratio (TTM)

Health Insurance Innovations, Inc. PE Ratio (TTM)

Health Insurance Innovations, Inc. pe-ratio-ttm | Health Insurance Innovations, Inc. Quote

LexinFintech Holdings Ltd. (LX): This online consumer finance platform has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 16.3% over the last 60 days.

LexinFintech Holdings Ltd. Sponsored ADR Price and Consensus

LexinFintech Holdings Ltd. Sponsored ADR Price and Consensus

LexinFintech Holdings Ltd. Sponsored ADR price-consensus-chart | LexinFintech Holdings Ltd. Sponsored ADR Quote

LexinFintech has a price-to-earnings ratio (P/E) of 8.18, compared with 8.40 for the industry. The company possesses a Value Score of A.

LexinFintech Holdings Ltd. Sponsored ADR PE Ratio (TTM)

LexinFintech Holdings Ltd. Sponsored ADR PE Ratio (TTM)

LexinFintech Holdings Ltd. Sponsored ADR pe-ratio-ttm | LexinFintech Holdings Ltd. Sponsored ADR Quote

SYNNEX Corporation (SNX): This business process services provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.9% over the last 60 days.

SYNNEX Corporation Price and Consensus

SYNNEX Corporation Price and Consensus

SYNNEX Corporation price-consensus-chart | SYNNEX Corporation Quote

SYNNEX has a price-to-earnings ratio (P/E) of 8.96 compared with 15.90 for the industry. The company possesses a Value Score of A.

SYNNEX Corporation PE Ratio (TTM)

SYNNEX Corporation PE Ratio (TTM)

SYNNEX Corporation pe-ratio-ttm | SYNNEX Corporation Quote

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
SYNNEX Corporation (SNX) : Free Stock Analysis Report
 
LexinFintech Holdings Ltd. Sponsored ADR (LX) : Free Stock Analysis Report
 
Health Insurance Innovations, Inc. (HIIQ) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.